Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Famvir

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 11 USDMF, 5 JDMF, 7 EU WC, 14 KDMF, 8 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

121 FDF Dossiers, 27 FDA Orange Book, 45 Europe, 9 Canada, 26 Australia, 6 South Africa, 8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 SPI Pharma, 12 DKSH, 4 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 6 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 1 ACG Worldwide, 5 Actylis, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 28 BASF, 1 Clariant, 10 Corel Pharma Chem, 7 DFE Pharma, 1 Finar, 12 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 4 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 12 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 48 Coating Systems & Additives, 38 Disintegrants & Superdisintegrants, 28 Thickeners and Stabilizers, 27 Solubilizers, 27 Direct Compression, 26 Granulation, 26 Controlled & Modified Release, 21 Lubricants & Glidants, 15 Topical, 15 Film Formers & Plasticizers, 11 Co-Processed Excipients, 10 Parenteral, 8 Chewable & Orodispersible Aids, 7 Emulsifying Agents, 7 Rheology Modifiers, 5 API Stability Enhancers, 5 Empty Capsules, 4 Taste Masking, 4 Coloring Agents, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

5 News #PharmaBuzz

5 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 62 Regulatory FDF Prices

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

13 Health Canada Patents

13 Health Canada Patents

REF. STANDARDS & IMPURITIES

7 Others

7 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	TAPI Technology & API Services	Israel	TAPI NL BV	17908	FAMCICLOVIR	2004-12-16	Active	II	Complete	2012-11-23	2012-11-08
28/03/2025	Aurobindo Pharma Limited	India	APITORIA PHARMA PRIVATE LTD	22204	FAMCICLOVIR USP	2008-11-19	Active	II	N/A

Famvir

Famvir

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers

11 USDMF

5 JDMF

7 EU WC

14 KDMF

8 NDC API

13 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

18 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

121 FDF Dossiers

27 FDA Orange Book

45 Europe

9 Canada

26 Australia

6 South Africa

8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

2 SPI Pharma

12 DKSH

4 Faran Shimi Pharmaceutical

5 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

6 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Pramukh Pharmachem

1 Zeal MediPharma

1 ACG Worldwide

5 Actylis

2 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

28 BASF

1 Clariant

10 Corel Pharma Chem

7 DFE Pharma

1 Finar

12 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

36 Kerry

3 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

2 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

3 Novo Excipients

5 Pharmatrans-Sanaq

4 Pluviaendo

5 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

15 Roquette

12 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

2 The Dow Chemical Company

1 Ulanqab Kema New Material

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders

48 Coating Systems & Additives

38 Disintegrants & Superdisintegrants

28 Thickeners and Stabilizers

27 Solubilizers

TABLET;ORAL - 125MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons